{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:58:21Z","timestamp":1781143101845,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lungcan.2026.109460","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:20:27Z","timestamp":1778811627000},"page":"109460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient and clinician preferences for adjuvant treatment following surgical resection in early-stage non-small cell lung cancer: A multi-country discrete choice experiment"],"prefix":"10.1016","volume":"217","author":[{"given":"Christine","family":"Michaels-Igbokwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Collacott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-6558","authenticated-orcid":false,"given":"Nicolas","family":"Krucien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sandelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8882-4359","authenticated-orcid":false,"given":"Rachel","family":"Salmonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3121-8238","authenticated-orcid":false,"given":"Leslie","family":"Servidio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2418-6969","authenticated-orcid":false,"given":"Yi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2026.109460_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109460_b0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40265-022-01721-3","article-title":"Neoadjuvant and adjuvant systemic therapy for early-stage non-small-cell lung cancer","volume":"82","author":"Isaacs","year":"2022","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109460_b0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.21037\/tlcr-22-723","article-title":"Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives","volume":"12","author":"Kris","year":"2023","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109460_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4046\/trd.2023.0085","article-title":"Recent advances in adjuvant therapy for non-small-cell lung cancer","volume":"87","author":"Kim","year":"2024","journal-title":"Tuberc Respir Dis (seoul)"},{"issue":"13","key":"10.1016\/j.lungcan.2026.109460_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137222","article-title":"Targeted therapy and immunotherapy in early-stage non-small cell lung cancer: current evidence and ongoing trials","volume":"23","author":"de Scordilli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109460_b0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR-mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109460_b0035","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109460_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032336","article-title":"Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments","volume":"10","author":"Sun","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.lungcan.2026.109460_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1062830","article-title":"Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives","volume":"14","author":"Oliveri","year":"2023","journal-title":"Front. Psychol."},{"issue":"21","key":"10.1016\/j.lungcan.2026.109460_b0050","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109460_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109460_b0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1470-2045(13)70158-X","article-title":"Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data","volume":"14","author":"Mauguen","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2026.109460_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.critrevonc.2017.11.014","article-title":"Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: a critical review","volume":"123","author":"Savina","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109460_b0070","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109460_b0075","article-title":"A study of patient preferences for the treatment of non-small cell lung cancer in Western China: a discrete-choice experiment","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.lungcan.2026.109460_b0080","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2147\/PPA.S224529","article-title":"Patient preferences for chemotherapy in the treatment of non-small cell lung cancer: a multicenter discrete choice experiment (DCE) study in China","volume":"13","author":"Sun","year":"2019","journal-title":"Patient Prefer. Adherence"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109460_b0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40271-021-00520-4","article-title":"A systematic review of discrete choice experiments in oncology treatments","volume":"14","author":"Collacott","year":"2021","journal-title":"Patient"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109460_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health\u2013a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.lungcan.2026.109460_b0095","unstructured":"The PREFER Consortium. PREFER Recommendations - Why, when and how to assess and use patient preferences in medical product decision-making. 2022 [cited 2022 Nov]; Available from: https:\/\/zenodo.org\/record\/6592304#.Y2VK8GnMKUl."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109460_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/S1556-0864(23)00358-1","article-title":"103P Patient and clinician perspectives on adjuvant treatment in early-stage non-small cell lung cancer (NSCLC): Qualitative results","volume":"18","author":"Collacott","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109460_b0105","unstructured":"National Institutes of Health. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017; Available from: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109460_b0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/01441640902827623","article-title":"Constructing efficient stated choice experimental designs","volume":"29","author":"Rose","year":"2009","journal-title":"Transp. Rev."},{"key":"10.1016\/j.lungcan.2026.109460_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocm.2019.100170","article-title":"Apollo: a flexible, powerful and customisable freeware package for choice model estimation and application","volume":"32","author":"Hess","year":"2019","journal-title":"Journal of Choice Modelling"},{"key":"10.1016\/j.lungcan.2026.109460_b0130","first-page":"54","article-title":"Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy","author":"Efron","year":"1986","journal-title":"Stat. Sci."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109460_b0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.23.00377","article-title":"Importance of low- and moderate-grade adverse events in patients' treatment experience and treatment discontinuation: an analysis of the E1912 trial","volume":"42","author":"O'Connell","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.lungcan.2026.109460_b0140","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2024-208803","article-title":"Patient preferences on clinical decision-making in myeloma: a 747-patient survey","volume":"144","author":"Mohyuddin","year":"2024","journal-title":"Blood"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:14:17Z","timestamp":1781140457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226005210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S0169500226005210"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109460","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and clinician preferences for adjuvant treatment following surgical resection in early-stage non-small cell lung cancer: A multi-country discrete choice experiment","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109460"}}